HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Parlux offers FY 2010 results

This article was originally published in The Rose Sheet

Executive Summary

Fragrance marketer posts loss of $14.8 mil. for fiscal 2010, ended March 31, compared with loss of $4.3 mil. in fiscal 2009. Sales of $148.1 mil. were down 2% on the year, attributed to expiration of firm's license for GUESS fragrances, lower consumer spending and high post-holiday returns. Impact from loss of GUESS "was considerably more than originally expected," according to CEO Frederick E. Purches. For fourth quarter, firm recorded sales of $17.7 mil., down 37% from the same period the year before, and a loss of $9.8 mil., versus a gain of $1.5 mil. in the prior-year quarter. Parlux executed an agreement with GE Capital Corporate Finance June 28 for $20 mil. in credit to fund future growth. The New York-based firm plans to focus on designer brands rather than the celebrity names that have dominated its roster of late (1"The Rose Sheet" June 21, 2010)
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

RS017040

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel